NCT02209623View on ClinicalTrials.gov

TDAP Safety in Pregnant Women

CompletedOBSERVATIONAL
Enrollment

375

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

May 31, 2016

Study Completion Date

December 18, 2017

Conditions
Pertussis
Interventions
BIOLOGICAL

TDAP

Trial Locations (2)

27705

Duke University Dept of ObGyn, Division of Maternal-Fetal Medicine, Durham

37232

Vanderbilt Medical Center, Vaccine Research Program, Nashville

Sponsors

Collaborators (1)

Duke University
All Listed Sponsors
collaborator

Duke University

OTHER

collaborator

Centers for Disease Control and Prevention

FED

lead

Vanderbilt University

OTHER

NCT02209623 - TDAP Safety in Pregnant Women | Biotech Hunter | Biotech Hunter